Latest News in the Life Sciences Industry
PR Newswire Association LLC.
FarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer
11 May 2026
GlobeNewswire
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
11 May 2026
GlobeNewswire
Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
11 May 2026
PR Newswire Association LLC.
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
11 May 2026
GlobeNewswire
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
10 May 2026
PR Newswire Association LLC.
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
09 May 2026
GlobeNewswire
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
08 May 2026
GlobeNewswire
Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares
08 May 2026
GlobeNewswire
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
07 May 2026
GlobeNewswire
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
GlobeNewswire
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07 May 2026
GlobeNewswire
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
07 May 2026
GlobeNewswire
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
07 May 2026
GlobeNewswire
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
06 May 2026
GlobeNewswire
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026
06 May 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan